Medycyna Paliatywna

The role of palliative medicine in the treatment of Parkinson’s disease – a neglected aspect of comprehensive medical care

  1. Klinika Medycyny Paliatywnej, Warszawski Uniwersytet Medyczny, Warszawa, Polska


  2. Caritas Diecezji Warszawsko-Praskiej, Warszawa, Polska


  3. Klinika Medycyny Paliatywnej, Warszawski Uniwersytet Medyczny, Warszawa, Polska


Medycyna Paliatywna 2026; 18(2)

Online publish date: 2026/06/05
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Parkinson’s disease is the second most common neurodegenerative disorder worldwide, leading to a significant psychophysical burden on both patients and their caregivers due to its progressive nature and wide spectrum of symptoms. However, it is still not an indication for palliative care in Poland. Numerous clinical studies demonstrate that early implementation of palliative care allows for treatment optimisation, significantly improving the quality of life in patients and their caregivers. The unpredictable trajectory and progressive character of the disease make advance care planning a crucial component of comprehensive treatment. Such a medical procedure increases respect for the patient’s autonomy, reduces levels of anxiety and depression among patients and their family members, and minimises the risk of medical interventions that could be considered as futile therapy. Patients with Parkinson’s disease require a personalised approach that integrates palliative care with neurological treatment. Establishing clear qualification criteria for palliative care, raising social awareness regarding its role in neurology, and training neurology specialists in basic palliative practices, but also improving access to multidisciplinary care through utilising digital solutions are key challenges on the way to a paradigm shift from disease-centred treatment to the holistic support of patients with Parkinson’s disease.

Share
without publication fees
without publication fees